Showing results (21-30 of 588) with videos related to

Sort By:
Pageof 59
Critical Reviews in Oncology/Hematology|July 1, 2018
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?Stefano Frega, Laura Bonanno, Valentina Guarneri, et al.
Critical Reviews in Oncology/Hematology|September 12, 2015
Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatmentLoredana Urso, Fiorella Calabrese, Adolfo Favaretto, et al.
Cancer Letters|August 22, 2006
Primary systemic therapy for operable breast cancer: a review of clinical trials and perspectivesValentina Guarneri, Antonio Frassoldati, Simona Giovannelli, et al.
Expert Review of Anticancer Therapy|August 7, 2018
Therapeutic approaches for T790M mutation positive non-small-cell lung cancerIlaria Attili, Niki Karachaliou, PierFranco Conte, et al.
Translational Lung Cancer Research|January 23, 2016
Platelets and their role in cancer evolution and immune systemNiki Karachaliou, Sara Pilotto, Emilio Bria, et al.
Expert Review of Anticancer Therapy|December 21, 2010
Timing for starting second-line therapy in recurrent ovarian cancerValentina Guarneri, Elena Barbieri, Maria Vittoria Dieci, et al.
Future Oncology (London, England)|April 7, 2020
Olaparib for advanced breast cancerGaia Griguolo, Maria Vittoria Dieci, Federica Miglietta, et al.
Clinical Pharmacokinetics|June 21, 2002
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugsRomano Danesi, Stefano Fogli, Alessandra Gennari, et al.
The Oncologist|June 28, 2014
Rare breast cancer subtypes: histological, molecular, and clinical peculiaritiesMaria Vittoria Dieci, Enrico Orvieto, Massimo Dominici, et al.
Drugs|March 28, 2007
Oral vinorelbine: role in the management of metastatic breast cancerMatti S Aapro, Pierfranco Conte, Emilio Esteban González, et al.
Pageof 59